An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about Beijing’s intentions.
Related Posts
What’s Wrong With Starbucks?
Prices are up—and so are the wait times. But that’s just the tip of the iced-latte-berg. The coffee giant’s new CEO will have his work […]
Atos Gets Revised Restructuring Proposal After Onepoint Withdrawal
Atos is in talks with bondholders and banks after a consortium that included shareholder Onepoint withdrew its rescue proposal, the latest setback for the struggling […]
Leaked Disney Data Reveals Financial and Strategy Secrets
A data trove from Disney that hackers leaked earlier this summer includes details about streaming revenue, park pricing and some staff and customers of Disney […]